Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)
China
· Delayed Price · Currency is CNY 27.50
+1.05 (3.97%)
Apr 29, 2026, 3:04 PM CST
SHE:300878 Revenue
In the year 2025, Zhejiang Wecome Pharmaceutical Company had annual revenue of 225.27M CNY, down -35.86%. Zhejiang Wecome Pharmaceutical Company had revenue of 73.95M in the quarter ending December 31, 2025, a decrease of -476.34%.
Revenue
225.27M
Revenue Growth
-35.86%
P/S Ratio
17.34
Revenue / Employee
346.57K
Employees
650
Market Cap
3.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 225.27M | -125.93M | -35.86% |
| Dec 31, 2024 | 351.20M | -168.42M | -32.41% |
| Dec 31, 2023 | 519.62M | -12.82M | -2.41% |
| Jan 1, 2023 | 532.44M | -100.51M | -15.88% |
| Jan 1, 2022 | 632.95M | 10.19M | 1.64% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baolingbao Biology | 2.81B |
| Guanhao Biotech | 387.75M |
| Shanghai Serum Bio-Technology | 197.68M |
| Qingdao Vland Biotech INC. | 1.37B |
| Hinova Pharmaceuticals | 46.50M |
| Boji Medical Technology | 949.94M |
| Pulike Biological Engineering | 1.09B |
| Shanghai Shen Lian Biomedical | 288.27M |